01.12.24 -- Repurposing A Cancer Drug For Alzheimer's Disease

Kristin Yarema, Ph.D., CEO, Poseida Therapeutics, sits down with Cell & Gene: The Podcast Host Erin Harris to discuss four of the biggest challenges the CGT sector faces when it comes to the development of off-the-shelf therapies. Kristin shares how 2024 might see some real progress in allogeneic therapies. Listen now!

Explore considerations for the series of characterizations necessary to ensure the efficacy of a packaging or device component and final drug delivery system.

Learn how to select an experienced nitrosamine mitigation provider and how a tailored, quantified strategy can help you bring your product into compliance while maintaining control of the process.

The standardization of biologics manufacturing processes has provided multiple options for producing mAbs, including building an in-house mAb production system or partnering with a contract manufacturer.

Consider this diverse range of real-world perspectives, complemented by data-driven insights, when looking to enhance the speed, accessibility, and efficiency of clinical trial processes.

Robust, low-maintenance integrations between ERP and specialty software can ensure a free flow of data to enable all-round visibility of activities and events in a life sciences company.